Literature DB >> 6217480

Comparison of the pharmacological actions of desmethylclomipramine and clomipramine.

J Maj, L Stala, Z Górka, A Adamus.   

Abstract

This research compares the effects, in mice and rats, of desmethylclomipramine (DCLOM) and clomipramine (CLOM). DCLOM antagonized the hypothermia induced in mice by reserpine or apomorphine to a much greater extent than CLOM. Reserpine ptosis in mice was depressed by DCLOM only. Similarly, only DCLOM was effective in the behavioral despair test in rats. DCLOM increased the 5-hydroxytryptamine (5-HT) pressor effect in pithed rats, but to a lesser extent than CLOM by several factors. Only DCLOM increased the noradrenaline (NA) pressor effect. The depletion of NA induced by 6-hydroxydopamine was depressed by DCLOM only. The 5-HT depletion induced by p-chloromethamphetamine was antagonized only by CLOM. The results obtained show that the noradrenergic mechanism is of prime importance in the action of DCLOM and of much more importance than in the action of CLOM.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6217480     DOI: 10.1007/bf00432256

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  29 in total

1.  Role of 5-hydroxytryptaminergic and adrenergic mechanism in antagonism of reserpine-induced hypothermia in mice.

Authors:  I H Slater; R C Rathbun; R Kattau
Journal:  J Pharm Pharmacol       Date:  1979-02       Impact factor: 3.765

2.  Action of serotoninmimetics in the behavioral despair test in rats.

Authors:  Z Górka; E Wojtasik; H Kwiatek; J Maj
Journal:  Commun Psychopharmacol       Date:  1979

3.  The ineffectiveness of desipramine pretreatment on behavioral effects of 6-hydroxydopamine in nialamide-pretreated rats.

Authors:  J Vetulani; K Reichenberg; G Wiszniowska
Journal:  Psychopharmacologia       Date:  1974

4.  The route of administration of imipramine as a factor affecting formation of its metabolite desipramine.

Authors:  W Daniel; A Adamus; M Melzacka; J Szymura
Journal:  J Pharm Pharmacol       Date:  1982-10       Impact factor: 3.765

5.  Plasma levels of chlorimipramine and its demethyl metabolite during treatment of depression.

Authors:  L Träskman; M Asberg; L Bertilsson; B Cronholm; B Mellström; L M Neckers; F Sjöqvist; P Thorén; G Tybring
Journal:  Clin Pharmacol Ther       Date:  1979-11       Impact factor: 6.875

6.  Clomipramine plasma level and clinical response.

Authors:  A D Broadhurst; H D James; L D Corte; A F Heeley
Journal:  Postgrad Med J       Date:  1977       Impact factor: 2.401

7.  Plasma level studies with clomipramine (anafranil)

Authors:  R B Jones; D K Luscombe
Journal:  J Int Med Res       Date:  1977       Impact factor: 1.671

8.  Effects of viloxazine, its optical isomers and its major metabolites on biogenic amine uptake mechanisms in vitro and in vivo.

Authors:  T P Blackburn; G A Foster; D T Greenwood; R Howe
Journal:  Eur J Pharmacol       Date:  1978-12-01       Impact factor: 4.432

9.  Tricyclic antidepressant agents. II. Effect of oral administration on the uptake of 3-H-noradrenaline and 14-C-5-hydroxytryptamine in slices of the midbrain-hypothalamus region of the rat.

Authors:  S B Ross; A L Renyi
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975

10.  Tricyclic antidepressant agents. I. Comparison of the inhibition of the uptake of 3-H-noradrenaline and 14-C-5-hydroxytryptamine in slices and crude synaptosome preparations of the midbrain-hypothalamus region of the rat brain.

Authors:  S B Ross; A L Renyi
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975
View more
  3 in total

1.  The effect of highly selective inhibitors of the uptake of noradrenaline or 5-hydroxytryptamine on TRH-induced hyperthermia in mice.

Authors:  L Pawłowski; H Kwiatek
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

2.  Ro 11-2465 (cyan-imipramine), citalopram and their N-desmethyl metabolites: effects on the uptake of 5-hydroxytryptamine and noradrenaline in vivo and related pharmacological activities.

Authors:  L Pawlowski; G Nowak; Z Górka; H Mazela
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 3.  Pharmacotherapy for trichotillomania.

Authors:  Jacob Hoffman; Taryn Williams; Rachel Rothbart; Jonathan C Ipser; Naomi Fineberg; Samuel R Chamberlain; Dan J Stein
Journal:  Cochrane Database Syst Rev       Date:  2021-09-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.